Obesity: Roche with first clinical data after US$2.7bn deal
Obesity candidate CT-388, which Genentech added to Roche's pipeline with the acquisition of Carmot Therapeutics, is at least not a disappointment, according to new trial data.<br /><br />
British PrecisionLife Ltd inks partnershipt with Metrodora Institute
British PrecisionLife Ltd and the Metrodora Institute have announced to launch clinical trials to improve the diagnosis and therapy of long COVID-related ME/CFS.
British PrecisionLife Ltd inks partnership with Metrodora Institute
British PrecisionLife Ltd and the Metrodora Institute have announced to launch clinical trials to improve the diagnosis and therapy of long COVID-related ME/CFS.
First dog snack from microbial protein
German-Portuguese biotech start-up MicroHarvest GmbH and a Munich-based pet food manufacturer want to launch the first dog snack made by single cell protein.<br /><br /><br />
AC Immune and Takeda ink US$2.1bn biobucks deal
AC Immune and Takeda have inked an exclusive option license agreement for ACI-24.060, a first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression. <ul><li></li></ul>
Memo Therapeutics AG increases Series C financing to CHF45m
Swiss antibody specialist Memo Therapeutics AG has added CHF20m to its Series C financing, bringing the total amount raised in the funding round to CHF 45 million. <br /><br />
Full house at European Cluster Conference
More than 900 experts from clusters and the EU Commission discussed at the sold-out 9<sup>th</sup> European Cluster Conference what cluster policy is needed to make Europe a world leader in […]
Danish 21st.BIO A/S opens multipurpose production plant
Danish CDMO 21st.BIO A/S has unveiled a new pilot plant facility to accelerate scaling of biotech processes ranging from food and beverages, agriculture, biomaterials, and biopharma. <br /> <br /><br […]
Protein flags Car-T cells for digestion by NK cells
Flagging of CAR-T cells with the B7H6 protein weakened the response to human leukaemia in models as it marks them for NK cell attack, German researchers report.
Biotalys starts field testing for biofungicide
Belgian AgTech specialist Biotalys BV an Agricultural Technology (AgTech) company has initiated field trials for BioFun-6, the company’s second llama-antibody-mimicking biofungicide program.